Sihuan Pharmaceutical Holdings Group (0460) Stock Statistics & Valuation Metrics

Sihuan Pharmaceutical Holdings Group has a market cap or net worth of HK$10.82B. The enterprise value is ―.

Sihuan Pharmaceutical Holdings Group has 9,329,999,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sihuan Pharmaceutical Holdings Group’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -2.05%.

The current PE Ratio of Sihuan Pharmaceutical Holdings Group is -26.51. Sihuan Pharmaceutical Holdings Group’s PEG ratio is 0.06.

In the last 12 months, Sihuan Pharmaceutical Holdings Group had revenue of 1.90B and earned -216.66M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was 36.46M and capital expenditures -48.34M, giving a free cash flow of -11.88M billion.

Sihuan Pharmaceutical Holdings Group pays an annual dividend of HK$0.02, resulting in a dividend yield of 1.81%

Sihuan Pharmaceutical Holdings Group upcoming earnings date is Sep 2, 2025, TBA Not Confirmed.

Sihuan Pharmaceutical Holdings Group as a current ratio of 1.73, with Debt / Equity ratio of 21.56%

In the past 12 months, Sihuan Pharmaceutical Holdings Group has paid 43.26M in taxes.

Sihuan Pharmaceutical Holdings Group EV to EBITDA ratio is -15.16, with an EV/FCF ratio of 0.00.

Sihuan Pharmaceutical Holdings Group has HK$3.63B in cash and marketable securities with ¥942.76M in debt, giving a net cash position of -HK$2.69B billion.

Gross margin is 65.32%, with operating margin of -7.27%, and net profit margin of -11.40%.

The average price target for Sihuan Pharmaceutical Holdings Group is ―, which is 11.43% higher than the current price. The consensus rating is ―